MedPath

BAROSENSE, INC.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)

Safety and Preliminary Effectiveness of the BaroSense Articulating Circular Endoscopic (ACE) Stapler for Plication of Dilated Post-surgical Gastric Anatomy

Not Applicable
Withdrawn
Conditions
Obese
First Posted Date
2011-07-07
Last Posted Date
2012-02-08
Lead Sponsor
BaroSense Inc.
Registration Number
NCT01388673

Multi-Center Feasibility Study of Trans-oral Endoscopic Restrictive Implant System (TERIS) for Treatment of Obesity

Phase 1
Completed
Conditions
Obesity
First Posted Date
2008-07-01
Last Posted Date
2013-04-10
Lead Sponsor
BaroSense Inc.
Target Recruit Count
40
Registration Number
NCT00707720
Locations
πŸ‡¨πŸ‡¦

Hopital Laval, Quebec City, Quebec, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.